Demoralization
8
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
13%
1 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Lysergic Acid Diethylamide (LSD) in Palliative Care
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Exploratory Study of Low Dose Psilocybin
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Ketamine-assisted Therapy for Advanced GI Cancer
Spiritual Well-being, Self-compassion, Physical Symptoms Distress and Demoralization Among HD Patients
Demoralization Among Palliative Care Patients and Their Family Caregivers in Hong Kong: A Pilot Study